SeptAsTERS- SeptiCyte® RAPID as assessment tool for early recognition of sepsis: a prospective observational study

Early recognition of sepsis is critical to patient outcome, with mortality increasing with every hour of delay in treatment. The aim of this study was to investigate the use of a point-of-care molecular host response assay to differentiate sepsis from inflammation after surgery.

Saved in:
Bibliographic Details
Main Authors: Forst, Maik von der (Author) , Back, Lisa (Author) , Tourelle, Kevin M. (Author) , Gruneberg, Daniel (Author) , Weigand, Markus A. (Author) , Schmitt, Felix (Author) , Dietrich, Maximilian (Author)
Format: Article (Journal)
Language:English
Published: 22 November 2024
In: Infection
Year: 2025, Volume: 53, Issue: 3, Pages: 953-965
ISSN:1439-0973
DOI:10.1007/s15010-024-02409-4
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s15010-024-02409-4
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s15010-024-02409-4
Get full text
Author Notes:M. von der Forst, L. Back, K.M. Tourelle, D. Gruneberg, M.A. Weigand, F.C.F. Schmitt, Maximilian Dietrich
Description
Summary:Early recognition of sepsis is critical to patient outcome, with mortality increasing with every hour of delay in treatment. The aim of this study was to investigate the use of a point-of-care molecular host response assay to differentiate sepsis from inflammation after surgery.
Item Description:Gesehen am 13.05.2025
Physical Description:Online Resource
ISSN:1439-0973
DOI:10.1007/s15010-024-02409-4